Many patients with high-risk biochemically recurrent prostate cancer based on PSA doubling time are unidentified in clinical practice. Clinicians unaware of patients’ PSA doubling time (PSADT) at ...
PSADT is vital for monitoring prostate cancer recurrence and guiding treatment decisions, yet often inaccurately calculated by physicians. Inconsistent PSADT documentation can lead to treatment delays ...
The Rule of 70 is a mathematical formula used to estimate the time it takes for an investment or any quantity to double, given a fixed annual growth rate. This rule is used by investors and financial ...